Revenue Carl Zeiss Meditec on all time high (consensus analysts)

Tomorrow the German Carl Zeiss Meditec will present her results over the past quarter. For this year the consensus of the revenue equals 1,09 million euros. The expectations would mean a record revenue for the company. This is a bit higher than the revenue over 2015 of 1,04 billion euros.

Historical revenues and results Carl Zeiss Meditec plus taxations 2016

historical prices

The analysts foresee for 2016 a net profit of 96 million euros. For the current year the consensus of the result per share is of profit of 1,19 euros. Based on this the price/earnings-ratio equals 26,76.

Per share a dividend of 0,47 cents is expected. The dividend yield consequently equals 1,48 percent. The average dividend of the pharmaceutical company equals 0,44 percent.

Latest target prices around 35 euros

Carl Zeiss Meditec is being covered by 10 analysts (only based on fundamental analysis). The average target price for the stock is at 32,52 euros. This is around 3 percent more than the current stock price of 31,84 euros. The 3 most recent recommendations for German were provided by Commerzbank (hold, 36,00 euros), Nord Landesbank (buy, 38,00 euros) and Deutsche Bank (hold, 31,00 euros).

Based on the number of outstanding shares Carl Zeiss Meditec 's market capitalization equals 2,59 billion euros.

At 10.43 the stock traded at 0,55 percent lower at 31,84 euros. News Wire & Equity Research: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.